CD25+Foxp3+ Regulatory T Cells Facilitate CD4+ T Cell Clonal Anergy Induction during the Recovery from Lymphopenia

Department of Medicine, Center for Immunology, University of Minnesota Medical School, 312 Church Street SE, Minneapolis, MN 55455, USA.
The Journal of Immunology (Impact Factor: 4.92). 06/2006; 176(10):5880-9. DOI: 10.4049/jimmunol.176.10.5880
Source: PubMed


T cell clonal anergy induction in lymphopenic nu/nu mice was found to be ineffective. Exposure to a tolerizing peptide Ag regimen instead induced aggressive CD4(+) cell cycle progression and increased Ag responsiveness (priming). Reconstitution of T cell-deficient mice by an adoptive transfer of mature peripheral lymphocytes was accompanied by the development of a CD25(+)Foxp3(+)CTLA-4(+)CD4(+) regulatory T cell population that acted to dampen Ag-driven cell cycle progression and facilitate the induction of clonal anergy in nearby responder CD25(-)CD4(+) T cells. Thus, an early recovery of CD25(+) regulatory T cells following a lymphopenic event can prevent exuberant Ag-stimulated CD4(+) cell cycle progression and promote the development of clonal anergy.

Download full-text


Available from: Marc Kevin Jenkins
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Worldwide, increasing numbers of patients are affected by end stage renal failure (ESRF). This mainly results from the ageing population and the global epidemic of type 2 diabetes. ESRF is generally caused by a loss of nephrons, which constitute the part of the kidney that filters waste products from the blood (figure 1). For several decades it has been appreciated that once a critical number of nephrons is lost, kidney failure will progress relentlessly towards ESRF, which means that the glomerular filtration rate (GFR) will become less than 60 ml per minute per 1.73 m2 body surface area. This severely reduced kidney function results in the accumulation of organic waste products, a state that is generally known as uremia. This uremic state is associated with a functionally impaired immune system, resulting in many clinical side effects as an increased incidence of infections and malignancies.
    Preview · Article ·

  • No preview · Article · Jul 2006 · Transplantation Reviews
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Allogeneic immune responses are modulated by a subset of host T cells with regulatory function (Treg) contained within the CD4(+)CD25(high) subset. Evidence exists that Treg expand after peritransplantation lymphopenia, inhibit graft rejection, and induce and maintain tolerance. Little, however, is known about the role of Treg in the clinical setting. IL-2 and activation by T cell receptor engagement are instrumental to generate and maintain Treg, but the influence of immunosuppressants on Treg homeostasis in humans in vivo has not been investigated. This study monitored Treg phenotype and function during immune reconstitution in renal transplant recipients who underwent profound T cell depletion with Campath-1H and received sirolimus or cyclosporine (CsA) as part of their maintenance immunosuppressive therapy. CD4(+)CD25(high) cells that expressed FOXP3 underwent homeostatic peripheral expansion during immune reconstitution, more intense in patients who received sirolimus than in those who were given CsA. T cells that were isolated from peripheral blood long term after transplantation were hyporesponsive to alloantigens in both groups. In sirolimus- but not CsA-treated patients, hyporesponsiveness was reversed by Treg depletion. T cells from CsA-treated patients were anergic. Thus, lymphopenia and calcineurin-dependent signaling seem to be primary mediators of CD4(+)CD25(high) Treg expansion in renal transplant patients. These findings will be instrumental in developing "tolerance permissive" immunosuppressive regimens in the clinical setting.
    Full-text · Article · Apr 2007 · Journal of the American Society of Nephrology
Show more